πŸ‡ΊπŸ‡Έ FDA
Patent

US 11702646

Methods for modulating RNA splicing

granted A61PA61P1/02A61P1/04

Quick answer

US patent 11702646 (Methods for modulating RNA splicing) held by PTC THERAPEUTICS, INC. expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P1/02, A61P1/04, A61P1/18, A61P11/02